Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 18 Jan 2022 |
10 | Certificate | 20 Jul 2024 |
2 | Reply to Exam Report (MIS-R) | 08 Feb 2022 |
3 | Reply to Exam Report (MIS-R) | 11 Feb 2022 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 07 Sep 2022 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 28 Feb 2023 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 23 Aug 2023 |
7 | Documents in support of Show cause Hearing (SCH) | 29 Jan 2024 |
8 | Authorization Letter | 02 Feb 2024 |
9 | Journal Copy | 29 Jun 2024 |
1 | EXAMINATION REPORT | 12977507 | 08 Feb 2022 | |
2 | Hearing Notice (Show Cause) | 17047159 | 05 Jan 2024 | |
3 | Tribunal Accepted Notice for : 5289085 | 17459577 | 6565087 | 20 Feb 2024 |
The application for Floxichoice was made on 18 January 2022.
The trademark applicant for Floxichoice is Abbott Healthcare Private Limited.
Floxichoice is applied in class(es) 5.
Application for Floxichoice is on Registered stage.
Application Id allotted to Floxichoice is 5289085.
Trademark agent or attorney for the application is Zeusip Advocates Llp.
Floxichoice filed with the Intellectual property office as a WORD.